Migraineとは - わかりやすく解説 Weblio辞書

ウィキペディア

索引トップ用語の索引ランキングカテゴリー

片頭痛

(Migraine から転送)

出典: フリー百科事典『ウィキペディア（Wikipedia）』 (2024/02/25 13:27 UTC 版)

片頭痛（へんずつう、migraine）とは、頭痛の一種で、偏頭痛とも表記する。発作的で脈打つような痛みや嘔吐などの症状を伴うのが特徴である。

脚注

注釈

^ しばしば、城の銃眼付き胸壁と勘違いされてきた^[25]。

出典

^ 片頭痛大正製薬ナロンシリーズ（2021年11月28日閲覧）
^ ^a ^b ^c ^d 「片頭痛、予防の時代へ新薬が原因物質に直接作用」『日本経済新聞』朝刊2021年11月16日（医療・健康面）2021年11月28日閲覧
^ ^a ^b ^c ^d ^e ^f Stovner LJ, Zwart JA, Hagen K, Terwindt GM, Pascual J (April 2006). “Epidemiology of headache in Europe”. European Journal of Neurology 13 (4): 333–45. doi:10.1111/j.1468-1331.2006.01184.x. PMID 16643310.
^ ^a ^b The International Classification of Headache Disorders, 2nd Edition
^ 英国国立医療技術評価機構 2012, Chapt.1.2.
^ “NINDS Migraine Information Page”. National Institute of Neurological Disorders and Stroke, National Institutes of Health. 2007年6月25日閲覧。
^ “Advances in Migraine Prophylaxis: Current State of the Art and Future Prospects” (PDF). National Headache Foundation (CME monograph). 2007年6月25日閲覧。
^ Gallagher RM, Cutrer FM (February 2002). “Migraine: diagnosis, management, and new treatment options”. The American Journal of Managed Care 8 (3 Suppl): S58–73. PMID 11859906.
^ Guidelines for all healthcare professionals in the diagnosis and management of migraine, tension-type, cluster and medication-overuse headache (Report). British Association for the Study of Headache. 2007年1月.
^ 英国国立医療技術評価機構 2012, Chapt.1.3.10.
^ Ogilvie AD, Russell MB, Dhall P, et al. (January 1998). “Altered allelic distributions of the serotonin transporter gene in migraine without aura and migraine with aura”. Cephalalgia 18 (1): 23–6. doi:10.1046/j.1468-2982.1998.1801023.x. PMID 9601620.
^ Gervil M, Ulrich V, Kaprio J, Olesen J, Russell MB (September 1999). “The relative role of genetic and environmental factors in migraine without aura”. Neurology 53 (5): 995–9. doi:10.1212/WNL.53.5.995. PMID 10496258.
^ Ulrich V, Gervil M, Kyvik KO, Olesen J, Russell MB (March 1999). “The inheritance of migraine with aura estimated by means of structural equation modelling”. Journal of Medical Genetics 36 (3): 225–7. doi:10.1136/jmg.36.3.225. PMC 1734315. PMID 10204850.
^ Goadsby PJ, Goldberg J, Silberstein SD (2008). “Migraine in pregnancy.”. BMJ 336 (7659): 1502-4. doi:10.1136/bmj.39559.675891.AD. PMC 2440903. PMID 18583683.
^ “Migraine During Pregnancy”. Practical Neurology (2019年5月). 2023年4月8日閲覧。
^ Headache Classification Subcommittee of the International Headache Society (2004). “The International Classification of Headache Disorders: 2nd edition”. Cephalalgia 24 Suppl 1: 9–160. doi:10.1111/j.1468-2982.2004.00653.x. PMID 14979299.
^ Lipton RB, Stewart WF, Celentano DD, Reed ML (June 1992). “Undiagnosed migraine headaches. A comparison of symptom-based and reported physician diagnosis”. Archives of Internal Medicine 152 (6): 1273–8. doi:10.1001/archinte.152.6.1273. PMID 1599358.
^ Schreiber CP, Hutchinson S, Webster CJ, Ames M, Richardson MS, Powers C (September 2004). “Prevalence of migraine in patients with a history of self-reported or physician-diagnosed 'sinus' headache”. Archives of Internal Medicine 164 (16): 1769–72. doi:10.1001/archinte.164.16.1769. PMID 15364670.
^ Detsky ME, McDonald DR, Baerlocher MO, Tomlinson GA, McCrory DC, Booth CM (September 2006). “Does this patient with headache have a migraine or need neuroimaging?”. JAMA 296 (10): 1274–83. doi:10.1001/jama.296.10.1274. PMID 16968852.
^ Lipton RB, Dodick D, Sadovsky R, et al. (August 2003). “A self-administered screener for migraine in primary care: The ID Migraine validation study”. Neurology 61 (3): 375–82. PMID 12913201.
^ Kelman L (October 2004). “The premonitory symptoms (prodrome): a tertiary care study of 893 migraineurs”. Headache 44 (9): 865–72. doi:10.1111/j.1526-4610.2004.04168.x. PMID 15447695.
^ Silberstein, Stephen D. (2005). Atlas Of Migraine And Other Headaches. London: Taylor & Francis Group. ISBN 1-84214-273-9 ^{[要ページ番号]}
^ Mathew, Ninan T.; Evans, Randolph W. (2005). Handbook of headache. Hagerstwon, MD: Lippincott Williams & Wilkins. ISBN 0-7817-5223-X ^{[要ページ番号]}
^ Silberstein, Stephen D. (2002). Headache in Clinical Practice (2nd ed.). London: Taylor & Francis Group. ISBN 1-901865-88-6 ^{[要ページ番号]}
^ ^a ^b 岩田誠「片頭痛の視覚前兆　―その歴史的展開―」『日本頭痛学会誌』第48巻第3号、2021年、doi:10.50860/jjho.48.3_549、ISSN 1345-6547。
^ Kelman L (February 2006). “The postdrome of the acute migraine attack”. Cephalalgia 26 (2): 214–20. doi:10.1111/j.1468-2982.2005.01026.x. PMID 16426278.
^ 『頭痛クリニック4』ISBN 9784787818096
^ Eur J Neurol. 2007 Sep;14(9):1053-6.Treatment of hemiplegic migraine with triptans.
^ Robbins MS, Lipton RB (April 2010). "The epidemiology of primary headache disorders". Seminars in Neurology. 30 (2): 107–19. doi:10.1055/s-0030-1249220. PMID 20352581。
^ Piane M, Lulli P, Farinelli I, Simeoni S, De Filippis S, Patacchioli FR, Martelletti P (December 2007). "Genetics of migraine and pharmacogenomics: some considerations". The Journal of Headache and Pain. 8 (6): 334–9. doi:10.1007/s10194-007-0427-2. PMC 2779399. PMID 18058067。
^ ^a ^b Bartleson JD, Cutrer FM (May 2010). "Migraine update. Diagnosis and treatment". Minnesota Medicine. 93 (5): 36–41. PMID 20572569。
^ ^a ^b ^c Schürks M (January 2012). "Genetics of migraine in the age of genome-wide association studies". The Journal of Headache and Pain. 13 (1): 1–9. doi:10.1007/s10194-011-0399-0. PMC 3253157. PMID 22072275。
^ de Vries B, Frants RR, Ferrari MD, van den Maagdenberg AM (July 2009). "Molecular genetics of migraine". Human Genetics. 126 (1): 115–32. doi:10.1007/s00439-009-0684-z. PMID 19455354. S2CID 20119237。
^ Montagna P (September 2008). "Migraine genetics". Expert Review of Neurotherapeutics. 8 (9): 1321–30. doi:10.1586/14737175.8.9.1321. PMID 18759544. S2CID 207195127。
^ Ducros A (May 2013). "[Genetics of migraine]". Revue Neurologique. 169 (5): 360–71. doi:10.1016/j.neurol.2012.11.010. PMID 23618705。
^ ^a ^b Simon RP, Aminoff MJ, Greenberg DA (2009). Clinical neurology (7 ed.). New York, N.Y: Lange Medical Books/McGraw-Hill. pp. 85–88. ISBN 9780071664332。
^ Wan D, Wang C, Zhang X, Tang W, Chen M, Dong Z, Yu S (1 January 2016). "Association between angiotensin-converting enzyme insertion/deletion polymorphism and migraine: a meta-analysis". The International Journal of Neuroscience. 126 (5): 393–9. doi:10.3109/00207454.2015.1025395. PMID 26000817. S2CID 34902092。
^ Dussor G, Cao YQ (October 2016). "TRPM8 and Migraine". Headache. 56 (9): 1406–1417. doi:10.1111/head.12948. PMC 5335856. PMID 27634619。
^ ^a ^b Levy D, Strassman AM, Burstein R (June 2009). "A critical view on the role of migraine triggers in the genesis of migraine pain". Headache. 49 (6): 953–7. doi:10.1111/j.1526-4610.2009.01444.x. PMID 19545256. S2CID 31707887。
^ Martin PR (June 2010). "Behavioral management of migraine headache triggers: learning to cope with triggers". Current Pain and Headache Reports. 14 (3): 221–7. doi:10.1007/s11916-010-0112-z. PMID 20425190. S2CID 5511782。
^ Pavlovic JM, Buse DC, Sollars CM, Haut S, Lipton RB (2014). "Trigger factors and premonitory features of migraine attacks: summary of studies". Headache. 54 (10): 1670–9. doi:10.1111/head.12468. PMID 25399858. S2CID 25016889。
^ Kantor, D (2006年11月21日). “MedlinePlus Medical Encyclopedia: Migraine”. 2008年4月4日閲覧。
^ ^a ^b “[Stress and migraine]”. Revue Neurologique 169 (5): 406–12. (May 2013). doi:10.1016/j.neurol.2012.11.008. PMID 23608071.
^ “The associations between migraine, unipolar psychiatric comorbidities, and stress-related disorders and the role of estrogen”. Current Pain and Headache Reports 13 (5): 404–12. (October 2009). doi:10.1007/s11916-009-0066-1. PMC 3972495. PMID 19728969.
^ Chai NC, Peterlin BL, Calhoun AH (June 2014). "Migraine and estrogen". Current Opinion in Neurology. 27 (3): 315–24. doi:10.1097/WCO.0000000000000091. PMC 4102139. PMID 24792340。
^ The Headaches, pp. 238–40
^ Finocchi C, Sivori G (May 2012). "Food as trigger and aggravating factor of migraine". Neurological Sciences. 33 Suppl 1 (1): S77-80. doi:10.1007/s10072-012-1046-5. PMID 22644176. S2CID 19582697。
^ Rockett FC, de Oliveira VR, Castro K, Chaves ML, Perla A, Perry ID (June 2012). "Dietary aspects of migraine trigger factors". Nutrition Reviews. 70 (6): 337–56. doi:10.1111/j.1753-4887.2012.00468.x. PMID 22646127。
^ “生活習慣で防ぐ「片頭痛」の傾向と対策 | 月別テーマ | サワイ健康推進課”. www.sawai.co.jp. 2018年12月6日閲覧。
^ link title Migraine Linked to Celiac Disease
^ Migraine Headaches: Gluten Triggers Severe Headaches in Sensitive Individuals
^ ^a ^b Holzhammer J, Wöber C (April 2006). “[Alimentary trigger factors that provoke migraine and tension-type headache]” (German). Schmerz 20 (2): 151–9. doi:10.1007/s00482-005-0390-2. PMID 15806385.
^ Sun-Edelstein C, Mauskop A (June 2009). “Foods and supplements in the management of migraine headaches”. The Clinical Journal of Pain 25 (5): 446–52. doi:10.1097/AJP.0b013e31819a6f65. PMID 19454881.
^ Yang WH, Drouin MA, Herbert M, Mao Y, Karsh J (June 1997). “The monosodium glutamate symptom complex: assessment in a double-blind, placebo-controlled, randomized study”. The Journal of Allergy and Clinical Immunology 99 (6 Pt 1): 757–62. doi:10.1016/S0091-6749(97)80008-5. PMID 9215242.
^ ^a ^b Millichap JG, Yee MM (January 2003). “The diet factor in pediatric and adolescent migraine”. Pediatric Neurology 28 (1): 9–15. doi:10.1016/S0887-8994(02)00466-6. PMID 12657413.
^ Tarasoff L, Kelly MF (December 1993). “Monosodium L-glutamate: a double-blind study and review”. Food and Chemical Toxicology 31 (12): 1019–35. doi:10.1016/0278-6915(93)90012-N. PMID 8282275.
^ “Low Tyramine Headache Diet” (PDF). National Headache Foundation (2004年). 2008年4月4日閲覧。
^ Jansen SC, van Dusseldorp M, Bottema KC, Dubois AE (September 2003). “Intolerance to dietary biogenic amines: a review”. Annals of Allergy, Asthma & Immunology 91 (3): 233–40; quiz 241–2, 296. PMID 14533654.
^ 井部明広「発酵食品に含まれるアミン類」（PDF）『東京都健康安全研究センター研究年報』第55号、東京都健康安全研究センター、2004年、13-22頁、ISSN 13489046、CRID 1522262181095749120。
^ http://www.eisai.jp/medical/products/maxalt/guidance/patient.html
^ Prince PB, Rapoport AM, Sheftell FD, Tepper SJ, Bigal ME (June 2004). “The effect of weather on headache”. Headache 44 (6): 596–602. doi:10.1111/j.1526-4610.2004.446008.x. PMID 15186304.
^ Cooke LJ, Rose MS, Becker WJ (January 2000). “Chinook winds and migraine headache”. Neurology 54 (2): 302–7. PMID 10668687.
^ Ravishankar K (November 2006). “'Hair wash' or 'head bath' triggering migraine - observations in 94 Indian patients”. Cephalalgia 26 (11): 1330–4. doi:10.1111/j.1468-2982.2006.01223.x. PMID 17059440.
^ Fragrance Migraine Triggers
^ ^a ^b ^c ^d ^e 柴田護「片頭痛の病態生理」『日本生理人類学会誌』第25巻第4号、日本生理人類学会、2020年、55-60頁、doi:10.20718/jjpa.25.4_55、ISSN 1342-3215。
^ http://ecfr.gpoaccess.gov/cgi/t/text/text-idx?c=ecfr&sid=a00605d20ab938aed6a579c5c6d2f5c5&rgn=div6&view=text&node=38:1.0.1.1.5.2&idno=38
^ Culpepper L (2009). “Generalized anxiety disorder and medical illness”. The Journal of Clinical Psychiatry 70 (Suppl 2): 20–4. doi:10.4088/JCP.s.7002.04. PMID 19371503.
^ Noseda R, Kainz V, Jakubowski M, et al. (February 2010). “A neural mechanism for exacerbation of headache by light”. Nature Neuroscience 13 (2): 239–45. doi:10.1038/nn.2475. PMC 2818758. PMID 20062053. 非専門家向けの内容要旨 – ScienceNOW (January 11, 2010).
^ ^a ^b ^c Alexander Mauskop; Fox, Barry (2001). What Your Doctor May Not Tell You About(TM): Migraines : The Breakthrough Program That Can Help End Your Pain. New York: Warner Books. ISBN 0-446-67826-0 ^{[要ページ番号]}
^ ^a ^b ^c ^d 永田栄一郎「片頭痛の病態に関する最新の知見」『臨床神経学』第60巻第1号、日本神経学会、2020年、doi:10.5692/clinicalneurol.cn-001348、ISSN 0009-918X、PMID 31852874。
^ 濱田潤一「教育講演4 片頭痛の病態生理―generatorを中心に―」『臨床神経学』第11巻第48号、日本神経学会、2008年、857-860頁、doi:10.5692/clinicalneurol.48.857、ISSN 0009918X。
^ Lauritzen M (February 1994). “Pathophysiology of the migraine aura. The spreading depression theory”. Brain 117 (1): 199–210. doi:10.1093/brain/117.1.199. PMID 7908596.
^ Hadjikhani N, Sanchez Del Rio M, Wu O, Schwartz D, Bakker D, Fischl B (2001). “Mechanisms of migraine aura revealed by functional MRI in human visual cortex.”. Proc Natl Acad Sci U S A 98 (8): 4687-92. doi:10.1073/pnas.071582498. PMC 31895. PMID 11287655.
^ Denuelle M, Fabre N, Payoux P, Chollet F, Geraud G (2007). “Hypothalamic activation in spontaneous migraine attacks”. Headache 47 (10): 1418–26. doi:10.1111/j.1526-4610.2007.00776.x. PMID 18052951.
^ 古和久典「片頭痛の病態と治療」『神経治療学』第39巻第3号、日本神経治療学会、2022年、200-203頁、doi:10.15082/jsnt.39.3_200、ISSN 0916-8443。
^ ^a ^b ^c ^d ^e Kaniecki R, Lucas S. (2004). “Treatment of primary headache: preventive treatment of migraine”. Standards of care for headache diagnosis and treatment. Chicago: National Headache Foundation. pp. 40–52
^ ^a ^b Brandes JL, Kudrow D, Stark SR, et al. (April 2007). “Sumatriptan-naproxen for acute treatment of migraine: a randomized trial”. JAMA 297 (13): 1443–54. doi:10.1001/jama.297.13.1443. PMID 17405970.
^ Lipton RB, Baggish JS, Stewart WF, Codispoti JR, Fu M (2000). “Efficacy and safety of acetaminophen in the treatment of migraine: results of a randomized, double-blind, placebo-controlled, population-based study”. Archives of Internal Medicine 160 (22): 3486–92. doi:10.1001/archinte.160.22.3486. PMID 11112243.
^ Goldstein J, Hoffman HD, Armellino JJ, et al. (September 1999). “Treatment of severe, disabling migraine attacks in an over-the-counter population of migraine sufferers: results from three randomized, placebo-controlled studies of the combination of acetaminophen, aspirin, and caffeine”. Cephalalgia 19 (7): 684–91. doi:10.1046/j.1468-2982.1999.019007684.x. PMID 10524663.
^ Center for Drug Evaluation and Research. “Excedrin Migraine Medication”. Excedrin. 2023年2月24日閲覧。
^ Cady R, Dodick DW (March 2002). "Diagnosis and treatment of migraine". Mayo Clinic Proceedings (英語). 77 (3): 255–261. doi:10.4065/77.3.255 (inactive 17 March 2010). PMID 11888029。
^ "Migraine headaches" information from the Cleveland Clinic
^ ^a ^b 菊井祥二, 竹島多賀夫「成熟したトリプタン治療も新規急性期治療薬の登場で変わるのか」『神経治療学』第37巻第4号、日本神経治療学会、2020年、680-684頁、doi:10.15082/jsnt.37.4_680、ISSN 0916-8443。
^ “＜新発売＞片頭痛治療剤「レイボー®錠 50mg/100mg」”. 日本イーライリリー株式会社、第一三共株式会社 (2022年6月8日). 2023年2月23日閲覧。
^ “レイボー(ラスミジタン)は冠動脈疾患・脳梗塞・不整脈・高血圧の既往など脳心血管系疾患リスクがある患者に投与可能か？。”. 日本イーライリリー株式会社 (2021年12月12日). 2023年2月23日閲覧。
^ Schmidt R, et al. A effect of caffeine on tntestinal absorption of ergotamine in man. Eur Clin Pharmacol 1974;7:213-6.
^ “カフェルゴット販売中止に伴う治療上の留意点”. 日本頭痛学会. 2023年2月23日閲覧。
^ ^a ^b ^c ^d ^e “頭痛の診療ガイドライン2021”. 医学書院 (2021年10月15日). 2023年2月23日閲覧。
^ Colman I, Friedman BW, Brown MD, et al. (June 2008). “Parenteral dexamethasone for acute severe migraine headache: meta-analysis of randomised controlled trials for preventing recurrence”. BMJ 336 (7657): 1359–61. doi:10.1136/bmj.39566.806725.BE. PMC 2427093. PMID 18541610.
^ Magnesium and Pain (Report). Nutrients. 2020年.
^ ^a ^b Migraine News for February 2005（2008年1月4日閲覧）
^ Orr SL, et al. Canadian Headache Society systematic review and recommendations on the treatment of migraine pain in emergency settings. Cephalalgia. 2015;35(3):271-284.
^ Diener H, Bussone G, de Liano H, Eikermann A, Englert R, Floeter T, Gallai V, Göbel H, Hartung E, Jimenez M, Lange R, Manzoni G, Mueller-Schwefe G, Nappi G, Pinessi L, Prat J, Puca F, Titus F, Voelker M (2004). “Placebo-controlled comparison of effervescent acetylsalicylic acid, sumatriptan and ibuprofen in the treatment of migraine attacks”. Cephalalgia 24 (11): 475. doi:10.1111/j.1468-2982.2004.00783.x. PMID 15482357.
^ Silberstein SD, Mannix LK, Goldstein J, et al. (2008). “Multimechanistic (sumatriptan-naproxen) early intervention for the acute treatment of migraine”. Neurology 71 (2): 114–21. doi:10.1212/01.wnl.0000316800.22949.20. PMID 18606965.
^ ^a ^b http://studylink.blogs.com/virtual-research-week/2009/04/vitamin-b-and-folate-fight-migraine.html
^ ^a ^b Schoenen,J., Jacquy, J., Lenaerts, M. (1998). “Effectiveness of high-dose riboflavin in migraine prophylaxis ： A randomized controlled trial.”. NEUROLOGY 50: 466-470.
^ Modi S, Lowder DM (January 2006). “Medications for migraine prophylaxis”. American Family Physician 73 (1): 72–8. PMID 16417067.
^ Diener HC, Limmroth V (August 2004). “Medication-overuse headache: a worldwide problem”. Lancet Neurology 3 (8): 475–83. doi:10.1016/S1474-4422(04)00824-5. PMID 15261608.
^ Fritsche G, Diener HC (November 2002). “Medication overuse headaches -- what is new?”. Expert Opinion on Drug Safety 1 (4): 331–8. doi:10.1517/14740338.1.4.331. PMID 12904133.
^ van der Kuy PH, Lohman JJ (May 2002). “A quantification of the placebo response in migraine prophylaxis”. Cephalalgia 22 (4): 265–70. doi:10.1046/j.1468-2982.2002.00363.x. PMID 12100088.
^ “カルシウム拮抗薬（片頭痛発作予防薬）の解説”. 日経メディカル処方薬事典. 2023年2月23日閲覧。
^ Saper JR, Lake AE, Tepper SJ.(2001) "Nefazodone for chronic daily headache prophylaxis: an open-label study." Headache. 2001 May;41(5):465-74.PMID 11380644
^ Mylecharane EJ.(1991)"5-HT2 receptor antagonists and migraine therapy."1: J Neurol. 1991;238 Suppl 1:S45-52.PMID 2045831
^ Millan MJ.(2005)"Serotonin 5-HT2C receptors as a target for the treatment of depressive and anxious states: focus on novel therapeutic strategies." 2005 Sep-Oct;60(5):441-60. PMID 16433010
^ “CGRP 関連新規片頭痛治療薬ガイドライン（暫定版）”. 日本頭痛学会. 2023年2月23日閲覧。
^ Blumenfeld AM, Stark RJ, Freeman MC, Orejudos A, Manack Adams A (2018). “Long-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine: COMPEL study.”. J Headache Pain 19 (1): 13. doi:10.1186/s10194-018-0840-8. PMC 5799088. PMID 29404713.
^ 石田和之「神経内科に役立つ漢方薬：症例と頻用処方」『臨床神経学』第53巻第11号、日本神経学会、2013年、938-941頁、doi:10.5692/clinicalneurol.53.938、ISSN 0009-918X、PMID 24291839。
^ Herbs at a glance - Feverfew (Report). アメリカ国立補完統合衛生センター. 2012年4月.
^ RK Cady, CP Schreiber, ME Beach, CC Hart (2005). “Gelstat Migraine (sublingually administered feverfew and ginger compound) for acute treatment of migraine when administered during the mild pain phase”. Medical Science Monitor 11 (9): PI65–9. PMID 16127373. See also summary poster
^ Russo, Ethan (1998). Cannabis for migraine treatment: the once and future prescription? An historical and scientific review. Pain 76:3-8.
^ ^a ^b Etminan M, Takkouche B, Isorna FC, et al. Risk of ischaemic stroke in people with migraine: Systematic review and meta-analysis of observational studies. BMJ. 2005;330:63. PMID 15596418
^ ^a ^b Kurth, T; Kurth T, Gaziano JM, Cook NR, Logroscino G, Diener HC, Buring JE (2006). “Migraine and risk of cardiovascular disease in women”. JAMA 296 (3): 283–91. doi:10.1001/jama.296.3.283. PMID 16849661.
^ Becker C, Brobert GP, Almqvist PM, Johansson S, Jick SS, Meier CR. Migraine and the risk of stroke, TIA, or death in the UK (CME). Headache. 2007;47(10):1374–84. PMID 18052947
^ Waters WE, Campbell MJ, Elwood PC. Migraine, headache, and survival in women. BMJ (Clin Res Ed). 1983;287:1442–1443. PMID 6416449
^ “片頭痛治療を目指した卵円孔開存のカテーテル閉鎖術：国内初の医師主導治験を開始”. 岡山大学 (2019年7月25日). 2023年4月2日閲覧。
^ “付録片頭痛に対する経皮的卵円孔閉鎖術に関するステートメント”. 日本頭痛学会 (2017年5月1日). 2023年4月2日閲覧。
^ Jette N, Patten S, Williams J, Becker W, Wiebe S (2008). “Comorbidity of migraine and psychiatric disorders--a national population-based study.”. Headache 48 (4): 501-16. doi:10.1111/j.1526-4610.2007.00993.x. PMID 18070059.
^ Radat F, Swendsen J (2005). “Psychiatric comorbidity in migraine: a review.”. Cephalalgia 25 (3): 165-78. doi:10.1111/j.1468-2982.2004.00839.x. PMID 15689191.
^ ^a ^b ^c ^d ^e 立花久大「片頭痛の共存症」『臨床神経学』第62巻第2号、日本神経学会、2022年、105-111頁、doi:10.5692/clinicalneurol.cn-001698、ISSN 0009-918X、PMID 35095052。
^ Hansen TF, Hoeffding LK, Kogelman L, Haspang TM, Ullum H, Sørensen E (2018). “Comorbidity of migraine with ADHD in adults.”. BMC Neurol 18 (1): 147. doi:10.1186/s12883-018-1149-6. PMC 6190553. PMID 30322380.
^ Ottman R, Lipton RB (1994). “Comorbidity of migraine and epilepsy”. Neurology 44 (11): 2105–10. PMID 7969967.
^ Mortimer MJ, Kay J, Jaron A (1992). “Epidemiology of headache and childhood migraine in an urban general practice using Ad Hoc, Vahlquist and IHS criteria”. Dev Med Child Neurol 34 (12): 1095–101. PMID 1451940.
^ Linet MS, Stewart WF, Celentano DD, Ziegler D, Sprecher M (1989). “An epidemiologic study of headache among adolescents and young adults”. JAMA 261 (15): e1197. doi:10.1001/jama.261.15.2211. PMID 2926969.
^ Ziegler DK, Hassanein RS, Couch JR (1977). “Characteristics of life headache histories in a nonclinic population”. Neurology 27 (3): 265–9. PMID 557763.
^ SELBY G, LANCE JW (1960). “Observations on 500 cases of migraine and allied vascular headache”. J. Neurol. Neurosurg. Psychiatr. 23: 23–32. doi:10.1136/jnnp.23.1.23. PMC 495326. PMID 14444681.
^ ^a ^b Anttila P, Metsähonkala L, Sillanpää M (2006). “Long-term trends in the incidence of headache in Finnish schoolchildren”. Pediatrics 117 (6): e1197–201. doi:10.1542/peds.2005-2274. PMID 16740819.
^ ^a ^b ^c Lipton RB, Stewart WF (1993). “Migraine in the United States: a review of epidemiology and health care use”. Neurology 43 (6 Suppl 3): S6–10. PMID 8502385.
^ ^a ^b Rasmussen BK, Olesen J (1992). “Migraine with aura and migraine without aura: an epidemiological study”. Cephalalgia 12 (4): 221–8; discussion 186. doi:10.1046/j.1468-2982.1992.1204221.x. PMID 1525797.
^ Steiner TJ, Scher AI, Stewart WF, Kolodner K, Liberman J, Lipton RB (2003). “The prevalence and disability burden of adult migraine in England and their relationships to age, gender and ethnicity”. Cephalalgia 23 (7): 519–27. doi:10.1046/j.1468-2982.2003.00568.x. PMID 12950377.
^ Bigal ME, Liberman JN, Lipton RB (2006). “Age-dependent prevalence and clinical features of migraine”. Neurology 67 (2): 246–51. doi:10.1212/01.wnl.0000225186.76323.69. PMID 16864816.
^ Stewart WF, Linet MS, Celentano DD, Van Natta M, Ziegler D (1991). “Age- and sex-specific incidence rates of migraine with and without visual aura”. Am. J. Epidemiol. 134 (10): 1111–20. PMID 1746521.
^ Wang SJ (2003). “Epidemiology of migraine and other types of headache in Asia”. Curr Neurol Neurosci Rep 3 (2): 104–8. doi:10.1007/s11910-003-0060-7. PMID 12583837.
^ Lavados PM, Tenhamm E (1997). “Epidemiology of migraine headache in Santiago, Chile: a prevalence study”. Cephalalgia 17 (7): 770–7. doi:10.1046/j.1468-2982.1997.1707770.x. PMID 9399008.
^ ^a ^b ^c Arulmani, U., "Calcitonin Gene-Related Peptide and Migraine: Implications for Therapy" (2004). Doctoral thesis, Erasmus University. Web-link.
^ Brothwell, Don R. (1963). Digging up Bones; the Excavation, Treatment and Study of Human Skeletal Remains. London: British Museum (Natural History). pp. 126. OCLC 14615536
^ Edmeads, J (1991). “What is migraine? Controversy and stalemate in migraine pathophysiology”. Journal of neurology (Springer) 238: S2-S5. doi:10.1007/BF01642898. https://doi.org/10.1007/BF01642898.
^ Cost of disorders of the brain in Europe
^ “日本頭痛学会京都頭痛宣言”. www.jhsnet.org. 日本頭痛学会 (2005年10月9日). 2019年1月24日閲覧。